Xiaofeng Li
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 1%
- Bone Metabolism and Diseases
- Circular RNAs in diseases
- RNA modifications and cancer
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
Papers in
-
- Cancer-related molecular mechanisms research 35
- MicroRNA in disease regulation 26
- Cancer, Hypoxia, and Metabolism 15
-
- Ovarian function and disorders 11
- Co-authors
- Yazhuo ZhangDianqing WuWenzhong LiuStephen E. HarrisPeng LiuJianghong ZhangHeeseog KangXiao‐Ming Meng
- Journals
- Frontiers in Pharmacology (7 papers)Biochemical and Biophysical Research Communications (7 papers)International Immunopharmacology (5 papers)Medicine (5 papers)Oncotarget (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaofeng Li
311 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Cancer Research 1.8k
- Molecular Biology 4.5k
- Orthopedics and Sports Medicine 452
- Reproductive Medicine 438
- Hepatology 380
Countries citing papers authored by Xiaofeng Li
This map shows the geographic impact of Xiaofeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Li more than expected).
Fields of papers citing papers by Xiaofeng Li
This network shows the impact of papers produced by Xiaofeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Li. The network helps show where Xiaofeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 20 | |
| 9 | 2023 | 21 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 10 | |
| 13 | 2021 | 98 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 3 | |
| 16 | 2021 | 12 | |
| 17 | 2021 | 16 | |
| 18 | 2020 | 22 | |
| 19 | 2019 | 1 | |
| 20 | 2017 | 181 |
About Xiaofeng Li
Xiaofeng Li is a scholar working on Cancer Research, Reproductive Medicine, Molecular Biology, Hepatology and Complementary and alternative medicine, having authored 330 papers that have together received 7.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (35 papers), MicroRNA in disease regulation (26 papers), RNA modifications and cancer (23 papers), Circular RNAs in diseases (22 papers), Liver Disease Diagnosis and Treatment (18 papers), Liver physiology and pathology (17 papers), Cancer, Hypoxia, and Metabolism (15 papers) and Ovarian function and disorders (11 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (4.5k citations), Orthopedics and Sports Medicine (452 citations), Reproductive Medicine (438 citations) and Hepatology (380 citations). Xiaofeng Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yazhuo Zhang, Dianqing Wu, Wenzhong Liu, Stephen E. Harris, Peng Liu, Jianghong Zhang, Heeseog Kang, Xiao‐Ming Meng, Cheng Huang and Jun Li. Their work appears in journals such as Frontiers in Pharmacology, Biochemical and Biophysical Research Communications, International Immunopharmacology, Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.